PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.\', \'Institute for Integrative Systems Biology (I2SysBio), Universitat de Valencia-CSIC, Valencia, Spain.\', \'Department of Microbiology, School of Medicine, University of Valencia, Av. Blasco Ibáñez 17, 46010, Valencia, Spain.\', \'Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain. david.navarro@uv.es.\', \'Department of Microbiology, School of Medicine, University of Valencia, Av. Blasco Ibáñez 17, 46010, Valencia, Spain. david.navarro@uv.es.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s10096-020-04128-8
?:hasPublicationType
?:journal
  • European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
is ?:pmid of
?:pmid
?:pmid
  • 33404891
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and chemiluminescent immunoassays.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all